General discussion, page-11319

Agree completely. What excites me is this part of the article which clearly points to commercialisation of the Soft Gel capsules once the OSA human trials come back successful. IHL have a strong clear mission to rapidly bring the product out to markets.

“Procaps will supply our clinical trial programs but can also quickly ramp up production for commercial supply upon successful clinical trial outcomes.”Procaps has already developed over 500 formulations for both pharmaceutical and nutritional products, stated it has reached over 50 markets globally.


And our SP is sitting at 55.5 ????? Crazy.

We are on the cusp of clinical successful trials and once these are announced, IHL will be massively undervalued and I am sure the Australian, European and US markets will catch on...